Fermenta Biotech Ltd

Company Profile

Fermenta Biotech Ltd had its IPO on under the ticker symbol FERMENTA.

The company operates in the sector and industry. Fermenta Biotech Ltd has a staff strength of 0 employees.

Stock update

Shares of Fermenta Biotech Ltd opened at ₹160 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹152.6 - ₹160.05, and closed at ₹154.4.

This is a -2.98% slip from the previous day's closing price.

A total volume of 16,598 shares were traded at the close of the day’s session.

In the last one week, shares of Fermenta Biotech Ltd have slipped by -2.06%.

Fermenta Biotech Ltd's Key Ratios

Fermenta Biotech Ltd has a market cap of ₹4.38 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Fermenta Biotech Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Fermenta Biotech Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Fermenta Biotech Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of -1499.71%.

In Q2, Fermenta Biotech Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Fermenta Biotech Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Fermenta Biotech Ltd’s profitability.

Fermenta Biotech Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Fermenta Biotech Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹6.36 billion

Total Liabilities

₹2.09 billion

Operating Cash Flow

₹-563200000.00

Capital Expenditure

₹404.89 million

Dividend Payout Ratio

0%

Fermenta Biotech Ltd ended 2024 with ₹6.36 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.36 billion while shareholder equity stood at ₹3.15 billion.

Fermenta Biotech Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹2.09 billion in other current liabilities, 144287000.00 in common stock, ₹3.00 billion in retained earnings and ₹115.30 million in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹613.97 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹835.89 million.

Fermenta Biotech Ltd’s total current assets stands at ₹2.53 billion while long-term investments were ₹0 and short-term investments were ₹31.17 million. Its net receivables were ₹448.69 million compared to accounts payable of ₹0 and inventory worth ₹1.30 billion.

In 2024, Fermenta Biotech Ltd's operating cash flow was ₹-563200000.00 while its capital expenditure stood at ₹404.89 million.

Comparatively, Fermenta Biotech Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹154.4

52-Week High

₹280

52-Week Low

₹103.3

Analyst Target Price

₹

Fermenta Biotech Ltd stock is currently trading at ₹154.4 per share. It touched a 52-week high of ₹280 and a 52-week low of ₹280. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹148.2 and 200-day moving average was ₹151.29 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.